Omega Fund Management, LLC
- SEC CIK
- 0001637359
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 13
- 0 vs. Q1 2025
- Portfolio value
- $154.4M
- −$15.0M (−8.9%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BBNXBeta Bionics, Inc. | COM | 1,988,287 | $28.9M | 18.7% | 00.0% | Unchanged | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 1,645,893 | $27.3M | 17.7% | −150,000−8.4% | Reduced | History |
| UPBUpstream Bio, Inc. | COM | 2,036,293 | $22.4M | 14.5% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 11,042,728 | $21.5M | 13.9% | −2,029,612−15.5% | Reduced | History |
| BCAXBicara Therapeutics Inc. | COM | 2,204,650 | $20.5M | 13.3% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 1,975,203 | $18.3M | 11.9% | 00.0% | Unchanged | History |
| LXEOLexeo Therapeutics, Inc. | COM | 1,184,636 | $4.76M | 3.1% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 2,249,123 | $3.01M | 2.0% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 843,750 | $2.30M | 1.5% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 653,223 | $1.96M | 1.3% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 526,357 | $1.92M | 1.2% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 1,788,160 | $1.25M | 0.8% | 00.0% | Unchanged | History |
| ENGNWenGene Therapeutics Inc. | *W EXP 10/31/202 | 321,502 | $273.0K | 0.2% | 00.0% | Unchanged | History |